HEALTH care giant Johnson & Johnson's third-quarter profit has edged up as a big jump in prescription drug sales and lower research spending made up for slumping sales of medical devices.
Its results beat Wall Street estimates and its shares rose 1.3 per cent to $US91 in premarket trading.
The maker of baby shampoo, joint replacements and drugs for immune disorders says net income was $US2.98 billion ($A3.15 billion), or $US1.04 per share, up from $US2.97 billion, or $US1.05 per share, a year earlier.
Excluding one-time charges, it earned $US1.36 per share. That was four cents per share better than analysts expected.
The company, based in New Brunswick, New Jersey, says revenue totaled $US17.58 billion, up three per cent. Analysts expected $US17.43 billion.
J&J nudged up its profit forecast to $US5.44 to $US5.49 per share. Analysts expect $US5.46 per share.
Anda sedang membaca artikel tentang
Johnson & Johnson 3Q net rises slightly
Dengan url
http://pepatahama.blogspot.com/2013/10/johnson-johnson-3q-net-rises-slightly.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Johnson & Johnson 3Q net rises slightly
namun jangan lupa untuk meletakkan link
Johnson & Johnson 3Q net rises slightly
sebagai sumbernya
0 komentar:
Posting Komentar